[1]冯思颖,吴威妮,褚庆民,等.基于网络药理学探讨葶苈大枣泻肺汤治疗慢性心力衰竭的作用机制[J].西部中医药,2021,34(05):26-31.[doi:10.12174/j.issn.2096-9600.2021.05.07]
　FENG Siying,WU Weini,CHU Qingmin,et al.The Mechanism of Tingli Dazao Xiefei Tang in Treating Chronic Heart Failure Based on Network Pharmacology[J].Western Journal of Traditional Chinese Medicine,2021,34(05):26-31.[doi:10.12174/j.issn.2096-9600.2021.05.07]
点击复制

基于网络药理学探讨葶苈大枣泻肺汤治疗慢性心力衰竭的作用机制
分享到：

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
34
期数:
2021年05期
页码:
26-31
栏目:
出版日期:
2021-05-15

文章信息/Info

Title:
The Mechanism of Tingli Dazao Xiefei Tang in Treating Chronic Heart Failure Based on Network Pharmacology
作者:
冯思颖1, 吴威妮1, 褚庆民2, 邱艺俊2, 李思宁2
1.广州中医药大学第一临床医学院，广东 广州 510000
2.广州中医药大学第一附属医院
Author(s):
FENG Siying1, WU Weini1, CHU Qingmin2, QIU Yijun2, LI Sining2
1.The First Clinical Medical School, Guangzhou University of Chinese Medicine, Guangzhou 510000, China
2.The First Affiliated Hospital of Guangzhou University of Chinese Medicine
关键词:
慢性心力衰竭; 网络药理学; 葶苈大枣泻肺汤
Keywords:
CHF; network pharmacology
分类号:
R285
DOI:
10.12174/j.issn.2096-9600.2021.05.07
摘要:
目的基于网络药理学探讨葶苈大枣泻肺汤治疗慢性心力衰竭（chronic heart failure，CHF）的机制。 方法利用中药系统药理学分析平台（traditional Chinese medicine systems pharmacology，TCMSP）获取葶苈子、大枣的活性成分，采用SwissTargetPrediction、GeneCards数据库、STRING数据库、DAVID 6.8数据库及软件筛选分析治疗CHF的作用靶点，进行基因本体论（gene ontology，GO）分类富集分析和京都基因与基因组百科全书（Kyoto Encyclopedia of Genes and Genomes，KEGG）通路富集分析。 结果筛选出葶苈子、大枣活性成分共42个，作用于498个靶点，主要通过PI3K/Akt信号通路、cAMP信号通路、钙离子信号通路、胰岛素抵抗、甲状腺激素信号通路、T细胞受体信号通路、HIF-1等信号通路作用于CHF。 结论葶苈大枣泻肺汤可通过多成分、多靶点、多通路治疗慢性心力衰竭。
Abstract:
ObjectiveTo discuss the mechanism of Tingli Dazao Xiefei Tang in treating CHF based on network pharmacology. MethodsActive ingredients of Tinglizi and Chinese date were gained using TCMSP, targets of treating CHF were selected and analyzed using SwissTargetPrediction, GeneCards database, STRING database, DAVID 6.8 database and software, to carry out classification and enrichment analysis of GO classification and enrichment analysis, and KEGG pathway enrichment analysis. ResultsA total of 42 active components were screened out from Tinglizi and Chinese date, which acted on 498 targets, and they mainly acted on CHF through phosphatidylinositol 3-kinase/serine threonine kinase (PI3K/Akt) signaling pathway, cAMP signaling pathway, calcium signaling pathway, insulin resistance, thyroid hormone signaling pathway, T cell receptor signaling pathway, hypoxia inducible factor-1 (HIF-1) and others. ConclusionTingli Dazao Xiefei Tang could treat CHF by multi-component, multi-target and multi-channel therapy.

相似文献/References:

[1]李清秀,陈守强△.从运气学说探讨乙未年慢性心力衰竭的诊治规律[J].西部中医药,2015,28(10):84.
[2]刘世梅,胡 琰,杜景柏,等.以心功能分级为依据的中医分型治疗慢性心力衰竭临床观察[J].西部中医药,2018,31(09):97.
　LIU Shimei,HU Yan,DU Jingbai,et al.Clinical Observation on Treating Chronic Congestive Heart Failure by TCM Pattern Treatment on the Foundation of Cardiac Functional Grading[J].Western Journal of Traditional Chinese Medicine,2018,31(05):97.
[3]刘明晖,赵树华△.五苓散治疗慢性心力衰竭60例[J].西部中医药,2017,30(02):74.
　LIU Minghui,ZHAO Shuhua.WuLing San in Treating 60 Cases of Chronic Heart Failure[J].Western Journal of Traditional Chinese Medicine,2017,30(05):74.
[4]李亮,姬艳苏△.黄芪总皂苷对心力衰竭大鼠JAK2和STAT3的影响[J].西部中医药,2018,31(09):17.
　LI Liang,JI Yansu.Effects of Total Saponins of HuangQi on JAK2/STAT3 of the Rats with Heart Failure[J].Western Journal of Traditional Chinese Medicine,2018,31(05):17.
[5]刘新宇,陈星宇,毕鸿昊,等.基于网络药理学和分子对接探讨枸杞子-菟丝子-当归治疗视网膜色素变性的作用机制[J].西部中医药,2025,38(12):79.[doi:10.12174/j.issn.2096-9600.2025.12.16]
　LIU Xinyu,CHEN Xingyu,BI Honghao,et al.Exploring the Mechanism of Action of Gouqizi-Tusizi-Angelica in the Treatment of Retinitis Pigmentosa Based on Network Pharmacology and Molecular Docking[J].Western Journal of Traditional Chinese Medicine,2025,38(05):79.[doi:10.12174/j.issn.2096-9600.2025.12.16]
[6]孙小静,张亚峰.参附注射液治疗慢性心力衰竭疗效观察[J].西部中医药,2019,32(05):84.
　SUN Xiaojing,ZHANG Yafeng.Clinical Observation on ShenFu Injection in the Treatment for Chronic Heart Failure[J].Western Journal of Traditional Chinese Medicine,2019,32(05):84.
[7]杨继红,姚帅君,贺文彬,等.基于数据挖掘和分子对接探讨含党参方剂治疗消渴用药规律及分子机制研究[J].西部中医药,2025,38(08):30.[doi:10.12174/j.issn.2096-9600.2025.08.08]
　YANG Jihong,YAO Shuaijun,HE Wenbin,et al.Medication Rules of Dangshen-containing Prescription in the Treatment of Diabetes Mellitus and Study on Molecular Mechanism: Based on Data Mining and Molecular Docking[J].Western Journal of Traditional Chinese Medicine,2025,38(05):30.[doi:10.12174/j.issn.2096-9600.2025.08.08]
[8]赵贺华,杨丽君.基于网络药理学探讨黄芩抗巨细胞病毒感染的作用机制[J].西部中医药,2025,38(08):37.[doi:10.12174/j.issn.2096-9600.2025.08.09]
　ZHAO Hehua,YANG Lijun.Network Pharmacology-based Discussion on the Mechanism of Huangqin in the Treatment of Cytomegalovirus Infection[J].Western Journal of Traditional Chinese Medicine,2025,38(05):37.[doi:10.12174/j.issn.2096-9600.2025.08.09]
[9]顾东彦,王子雯,许孟月,等.基于网络药理学及分子对接探讨参苓白术散治疗特应性皮炎的作用机制[J].西部中医药,2025,38(08):45.[doi:10.12174/j.issn.2096-9600.2025.08.10]
　GU Dongyan,WANG Ziwen,XU Mengyue,et al.Mechanism of Shenling Baizhu Powder in the Treatment of Atopic Dermatitis Based on Network Pharmacology and Molecular Docking[J].Western Journal of Traditional Chinese Medicine,2025,38(05):45.[doi:10.12174/j.issn.2096-9600.2025.08.10]
[10]余林波,周鹍,林谦,等.基于网络药理学和分子对接技术探讨芪参六味方治疗心肌纤维化的作用机制[J].西部中医药,2025,38(08):51.[doi:10.12174/j.issn.2096-9600.2025.08.11]
　YU Linbo,ZHOU Kun,LIN Qian,et al.Based on Network Pharmacology and Molecular Docking: Treatment of Myocardial Fibrosis with Qishen Six-flavor Prescription[J].Western Journal of Traditional Chinese Medicine,2025,38(05):51.[doi:10.12174/j.issn.2096-9600.2025.08.11]

备注/Memo

备注/Memo:
冯思颖（1994—）女，在读硕士研究生。研究方向：心血管疾病的中医药防治。广东省自然科学基金（2017A030313745）；广东省中医药局项目（20181087）；广东省医学科学技术研究基金（A2018222）。
更新日期/Last Update: 2021-05-15